万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学

THERAPEUTIC ADVANCES IN CHRONIC DISEASE《慢性病治疗进展》 (官网投稿)

简介
  • 期刊简称THER ADV CHRONIC DIS
  • 参考译名《慢性病治疗进展》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率0.80%
  • 主要研究方向医学-PHARMACOLOGY & PHARMACY 药学

主要研究方向:

等待设置主要研究方向
医学-PHARMACOLOGY & PHARMACY 药学

THERAPEUTIC ADVANCES IN CHRONIC DISEASE《慢性病治疗进展》(月刊). Therapeutic Advances in Chronic Disease (TACD) is a peer-reviewed open access journal&...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:https://journals.sagepub.com/home/taj

3投稿网址:http://mc.manuscriptcentral.com/tacd

4、官网邮箱:TAChronicDisease@sagepub.co.uk(编辑部)

5、期刊刊期:月刊,一年出版12期。

2021年8月19日星期

                                 

 

投稿须知【官网信息】

 

Manuscript Submission Guidelines: Therapeutic Advances in Chronic Disease

This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/tacd to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

Only manuscripts of sufficient quality that meet the aims and scope of Therapeutic Advances in Chronic Disease will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

Therapeutic Advances in Chronic Disease may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.

If your paper is accepted, you must include a link on your preprint to the final version of your paper.

Citing preprints is permitted if no peer reviewed version of the article has been published.

1. Open Access

Therapeutic Advances in Chronic Disease is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

2. Article processing charge (APC)

Unsolicited manuscripts submitted to Therapeutic Advances in Chronic Disease are currently subject to an Article Processing Charge (APC) of 2300 USD* payable upon acceptance. These articles will be published under a Creative Commons Licence and will be made openly available.

……

更多详情:

https://journals.sagepub.com/author-instructions/TAJ


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭